Australia: Recall APO-Metformin XR 1000 mg tablets - risk of injury due to potential contamination with plastic fragment (English Only)
The Therapeutic Goods Administration (TGA) advised consumers and health professionals that Apotex, in consultation with the TGA, is recalling one batch of APO-Metformin XR 1000 mg tablets (batch number E16539). 

There has been one report of a small piece of white plastic (likely from a cable/zip tie) being embedded in a tablet from this batch. The plastic may or may not be visible, as it could be completely embedded in the tablet. If a small piece of plastic is swallowed with the tablet there is a small risk of choking or perforation of the gastrointestinal tract. The plastic is not toxic or carcinogenic. 

Please refer to the following website in TGA for details: 

In Hong Kong, the above product is not a registered pharmaceutical product. 

Ends/ Saturday, Jan 20, 2018 
Issued at HKT 12:00